As noticed earlier, HCV-mediated fibrosis appears tightly linked to liver inflammation, with on the one hand viral proteins (core, NS3, NS5A) acting as modulators of inflammation pathways and on the other hand inflammation mediators such as COX-2 acting as regulators of liver fibrosis. Here, KRAS is linked to Hepatic fibrosis.